mRNA |
blebbistatin |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.3 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.3 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.3 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.3 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.3 |